Development of Antiretroviral Rings for HIV Prevention

To evaluate a topical HIV prevention product using a nonhuman primate, repeat low dose model to define activity and toxicity of an intravaginal ring product.
Funding Partners:
  • Oak Crest Institute of Science
Program Partners:
  • CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Program Location:
  • United States of America